SCH 39166, a novel dopamine D1 receptor antagonist: In vitro investigation of its glucuronidation and potential species differences

Drug Development Research ◽

10.1002/ddr.430260403 ◽

1992 ◽

Vol 26 (4) ◽

pp. 389-403 ◽

Author(s):

Clark E. Tedford ◽

Vilma B. Ruperto ◽

Vicki L. Coffin ◽

Mary Cohen ◽

Michele Libonati ◽

...

Keyword(s):

Receptor Antagonist ◽

Species Differences ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Sch 39166 ◽

In Vitro Investigation ◽

D1 Receptor Antagonist

Download Full-text

Effects of the dopamine D1 receptor antagonist SCH 39166 on the ingestive behaviour of alcohol-preferring rats

Psychopharmacology ◽

10.1007/bf02246198 ◽

1995 ◽

Vol 120 (2) ◽

pp. 227-235 ◽

Author(s):

I. Panocka ◽

R. Ciccocioppo ◽

M. Mosca ◽

C. Polidori ◽

M. Massi

Keyword(s):

Receptor Antagonist ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Sch 39166 ◽

Ingestive Behaviour ◽

D1 Receptor Antagonist

Download Full-text

Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices

European Journal of Pharmacology ◽

10.1016/0014-2999(92)90525-9 ◽

1992 ◽

Vol 211 (2) ◽

pp. 169-176 ◽

Author(s):

C.E. Tedford ◽

G. Crosby ◽

L.C. Iorio ◽

R.E. Chipkin

Keyword(s):

Receptor Antagonist ◽

Acetylcholine Release ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Striatal Slices ◽

Sch 39166 ◽

D1 Receptor Antagonist

Download Full-text

The reversal of extrapyramidal side effects with SCH 39166, a dopamine D1 receptor antagonist

European Journal of Pharmacology ◽

10.1016/0014-2999(91)90268-u ◽

1991 ◽

Vol 202 (1) ◽

pp. 133-134 ◽

Author(s):

Daniel McHugh ◽

Vicki Coffin

Keyword(s):

Side Effects ◽

Receptor Antagonist ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Extrapyramidal Side Effects ◽

Sch 39166 ◽

D1 Receptor Antagonist

Download Full-text

Dopamine D1 receptor antagonist reduces stimulant-induced conditioned place preferences and dopamine receptor supersensitivity

Naunyn-Schmiedeberg s Archives of Pharmacology ◽

10.1007/s00210-019-01694-3 ◽

2019 ◽

Vol 393 (1) ◽

pp. 131-138 ◽

Author(s):

Sun Mi Gu ◽

Hye Jin Cha ◽

So Woon Seo ◽

Jin Tae Hong ◽

Jaesuk Yun

Keyword(s):

Receptor Antagonist ◽

Dopamine Receptor ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Receptor Supersensitivity ◽

Dopamine Receptor Supersensitivity ◽

Conditioned Place Preferences ◽

Place Preferences ◽

D1 Receptor Antagonist

Download Full-text

Selective alterations of the first NREM sleep cycle in humans by a dopamine D1 receptor antagonist (NNC-687)

Journal of Psychiatric Research ◽

10.1016/s0022-3956(03)00007-4 ◽

2003 ◽

Vol 37 (4) ◽

pp. 305-312 ◽

Author(s):

Derek N. Eder ◽

Milan Zdravkovic ◽

Gordon Wildschiødtz

Keyword(s):

Receptor Antagonist ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Sleep Cycle ◽

D1 Receptor Antagonist

Download Full-text

Effects of Electroacupuncture plus dopamine D1 receptor antagonist on somatosensory evoked potentials and behavioral changes in rats with cerebral ischemia-reperfusion

Journal of Acupuncture and Tuina Science ◽

10.1007/s11726-012-0589-6 ◽

2012 ◽

Vol 10 (3) ◽

pp. 133-137 ◽

Author(s):

Cheng-yong Liu ◽

Ming-shu Xu ◽

Lin-bao Ge

Keyword(s):

Cerebral Ischemia ◽

Evoked Potentials ◽

Receptor Antagonist ◽

Somatosensory Evoked Potentials ◽

Ischemia Reperfusion ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Behavioral Changes ◽

Cerebral Ischemia Reperfusion ◽

D1 Receptor Antagonist

Download Full-text

A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2016.04.012 ◽

2016 ◽

Vol 118 (3) ◽

pp. 160-166 ◽

Author(s):

Tanya Khasnavis ◽

Rosa J. Torres ◽

Barbara Sommerfeld ◽

Juan Garcia Puig ◽

Richard Chipkin ◽

...

Keyword(s):

Receptor Antagonist ◽

Crossover Trial ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Double Blind ◽

Double Blind Placebo ◽

Selective Dopamine ◽

D1 Receptor Antagonist

Download Full-text

Effects of the dopamine D1 receptor antagonist SCH23390 on self-administration of cocaine and fentanyl by rats trained on a progressive ratio reinforcement schedule.

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)50372-9 ◽

1994 ◽

Vol 64 ◽

pp. 182

Author(s):

Yasuyuki Awasaki ◽

Nobuyuki Nishida ◽

Satoshi Sasaki ◽

Shuzo Sato

Keyword(s):

Receptor Antagonist ◽

Reinforcement Schedule ◽

Progressive Ratio ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Self Administration ◽

D1 Receptor Antagonist

Download Full-text

The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons

Neuroscience Letters ◽

10.1016/0304-3940(95)12025-y ◽

1995 ◽

Vol 199 (1) ◽

pp. 13-16 ◽

Author(s):

Stephen R. Wachtel ◽

Francis J. White

Keyword(s):

Nucleus Accumbens ◽

Receptor Antagonist ◽

Sch 23390 ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Rat Nucleus Accumbens ◽

D1 Receptor Antagonist

Download Full-text

A dopamine D1 receptor antagonist, SCH 23390, selectively blocks vasopressin release after noxious stimuli in the rat

Neuroscience Letters ◽

10.1016/0304-3940(92)90038-9 ◽

1992 ◽

Vol 136 (2) ◽

pp. 157-160 ◽

Author(s):

Tatsushi Onaka ◽

Hidetaka Torigoe ◽

Kinji Yagi

Keyword(s):

Receptor Antagonist ◽

Sch 23390 ◽

Dopamine D1 Receptor ◽

D1 Receptor ◽

Vasopressin Release ◽

Noxious Stimuli ◽

D1 Receptor Antagonist

Download Full-text